Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.9134 |
High Similarity |
NPD9494 |
Approved |
0.912 |
High Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.856 |
High Similarity |
NPD5536 |
Phase 2 |
0.8356 |
Intermediate Similarity |
NPD1934 |
Approved |
0.8311 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.8299 |
Intermediate Similarity |
NPD2801 |
Approved |
0.8226 |
Intermediate Similarity |
NPD228 |
Approved |
0.8182 |
Intermediate Similarity |
NPD1511 |
Approved |
0.8069 |
Intermediate Similarity |
NPD1512 |
Approved |
0.8056 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.8054 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.803 |
Intermediate Similarity |
NPD3972 |
Approved |
0.7972 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7971 |
Intermediate Similarity |
NPD1240 |
Approved |
0.7971 |
Intermediate Similarity |
NPD943 |
Approved |
0.7943 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7914 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7891 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7872 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.7857 |
Intermediate Similarity |
NPD1607 |
Approved |
0.7829 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7821 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.7821 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.7821 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.7812 |
Intermediate Similarity |
NPD5283 |
Phase 1 |
0.7786 |
Intermediate Similarity |
NPD447 |
Suspended |
0.7785 |
Intermediate Similarity |
NPD824 |
Approved |
0.7778 |
Intermediate Similarity |
NPD1876 |
Approved |
0.7763 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7762 |
Intermediate Similarity |
NPD2344 |
Approved |
0.7754 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.7722 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.7674 |
Intermediate Similarity |
NPD1241 |
Discontinued |
0.7673 |
Intermediate Similarity |
NPD7054 |
Approved |
0.7671 |
Intermediate Similarity |
NPD2354 |
Approved |
0.7667 |
Intermediate Similarity |
NPD3455 |
Phase 2 |
0.7655 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7652 |
Intermediate Similarity |
NPD9545 |
Approved |
0.7625 |
Intermediate Similarity |
NPD7472 |
Approved |
0.7625 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.7616 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.7586 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.7582 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.758 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.7568 |
Intermediate Similarity |
NPD6799 |
Approved |
0.7566 |
Intermediate Similarity |
NPD6386 |
Approved |
0.7566 |
Intermediate Similarity |
NPD6385 |
Approved |
0.7551 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7551 |
Intermediate Similarity |
NPD2309 |
Approved |
0.755 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7547 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7536 |
Intermediate Similarity |
NPD2798 |
Approved |
0.7535 |
Intermediate Similarity |
NPD1933 |
Approved |
0.7518 |
Intermediate Similarity |
NPD1283 |
Approved |
0.7517 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.7517 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.7517 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD3021 |
Approved |
0.75 |
Intermediate Similarity |
NPD1608 |
Approved |
0.75 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.75 |
Intermediate Similarity |
NPD9269 |
Phase 2 |
0.75 |
Intermediate Similarity |
NPD3022 |
Approved |
0.7483 |
Intermediate Similarity |
NPD8166 |
Discontinued |
0.7469 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.7466 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.7464 |
Intermediate Similarity |
NPD1203 |
Approved |
0.7463 |
Intermediate Similarity |
NPD1651 |
Approved |
0.7436 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.7423 |
Intermediate Similarity |
NPD7685 |
Pre-registration |
0.7423 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.7419 |
Intermediate Similarity |
NPD5978 |
Approved |
0.7419 |
Intermediate Similarity |
NPD5977 |
Approved |
0.7397 |
Intermediate Similarity |
NPD2353 |
Approved |
0.7397 |
Intermediate Similarity |
NPD2355 |
Clinical (unspecified phase) |
0.7379 |
Intermediate Similarity |
NPD651 |
Clinical (unspecified phase) |
0.7378 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.7378 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.7372 |
Intermediate Similarity |
NPD1481 |
Phase 2 |
0.7365 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7365 |
Intermediate Similarity |
NPD4110 |
Phase 3 |
0.7365 |
Intermediate Similarity |
NPD4109 |
Clinical (unspecified phase) |
0.7362 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7355 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.7346 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7342 |
Intermediate Similarity |
NPD5494 |
Approved |
0.7338 |
Intermediate Similarity |
NPD6873 |
Phase 2 |
0.7333 |
Intermediate Similarity |
NPD4357 |
Discontinued |
0.7329 |
Intermediate Similarity |
NPD2796 |
Approved |
0.7325 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.7324 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.7324 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.7324 |
Intermediate Similarity |
NPD3764 |
Approved |
0.7315 |
Intermediate Similarity |
NPD3887 |
Approved |
0.7305 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.7299 |
Intermediate Similarity |
NPD1535 |
Discovery |
0.7299 |
Intermediate Similarity |
NPD1281 |
Approved |
0.7299 |
Intermediate Similarity |
NPD1547 |
Clinical (unspecified phase) |
0.7296 |
Intermediate Similarity |
NPD2821 |
Approved |
0.7292 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.7285 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.7279 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7279 |
Intermediate Similarity |
NPD17 |
Approved |
0.7273 |
Intermediate Similarity |
NPD7028 |
Phase 2 |
0.7273 |
Intermediate Similarity |
NPD4062 |
Phase 3 |
0.7273 |
Intermediate Similarity |
NPD6233 |
Phase 2 |
0.7273 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.726 |
Intermediate Similarity |
NPD4308 |
Phase 3 |
0.7259 |
Intermediate Similarity |
NPD1894 |
Discontinued |
0.7254 |
Intermediate Similarity |
NPD7095 |
Approved |
0.7248 |
Intermediate Similarity |
NPD7003 |
Approved |
0.7246 |
Intermediate Similarity |
NPD9717 |
Approved |
0.7246 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7244 |
Intermediate Similarity |
NPD1006 |
Clinical (unspecified phase) |
0.7244 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.7239 |
Intermediate Similarity |
NPD9493 |
Approved |
0.7234 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.7226 |
Intermediate Similarity |
NPD3847 |
Discontinued |
0.7222 |
Intermediate Similarity |
NPD1613 |
Approved |
0.7222 |
Intermediate Similarity |
NPD3620 |
Phase 2 |
0.7222 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.7222 |
Intermediate Similarity |
NPD3142 |
Approved |
0.7222 |
Intermediate Similarity |
NPD3619 |
Clinical (unspecified phase) |
0.7222 |
Intermediate Similarity |
NPD1558 |
Phase 1 |
0.7222 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.7222 |
Intermediate Similarity |
NPD3140 |
Approved |
0.7219 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7209 |
Intermediate Similarity |
NPD9265 |
Clinical (unspecified phase) |
0.7209 |
Intermediate Similarity |
NPD1358 |
Approved |
0.7206 |
Intermediate Similarity |
NPD1357 |
Approved |
0.7206 |
Intermediate Similarity |
NPD9268 |
Approved |
0.7205 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.7203 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7203 |
Intermediate Similarity |
NPD3268 |
Approved |
0.7194 |
Intermediate Similarity |
NPD2983 |
Phase 2 |
0.7194 |
Intermediate Similarity |
NPD2982 |
Phase 2 |
0.719 |
Intermediate Similarity |
NPD6662 |
Clinical (unspecified phase) |
0.7183 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.7179 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.7172 |
Intermediate Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.717 |
Intermediate Similarity |
NPD919 |
Approved |
0.7162 |
Intermediate Similarity |
NPD7266 |
Discontinued |
0.7154 |
Intermediate Similarity |
NPD9296 |
Approved |
0.7153 |
Intermediate Similarity |
NPD2674 |
Phase 3 |
0.7133 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.7126 |
Intermediate Similarity |
NPD3534 |
Clinical (unspecified phase) |
0.7124 |
Intermediate Similarity |
NPD6273 |
Approved |
0.7124 |
Intermediate Similarity |
NPD5049 |
Phase 3 |
0.7122 |
Intermediate Similarity |
NPD2981 |
Phase 2 |
0.7118 |
Intermediate Similarity |
NPD6377 |
Clinical (unspecified phase) |
0.7115 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.7111 |
Intermediate Similarity |
NPD405 |
Clinical (unspecified phase) |
0.7099 |
Intermediate Similarity |
NPD5242 |
Approved |
0.7097 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7095 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7092 |
Intermediate Similarity |
NPD2797 |
Approved |
0.7092 |
Intermediate Similarity |
NPD1470 |
Approved |
0.7089 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.7083 |
Intermediate Similarity |
NPD411 |
Approved |
0.7083 |
Intermediate Similarity |
NPD3144 |
Approved |
0.7083 |
Intermediate Similarity |
NPD3145 |
Approved |
0.7081 |
Intermediate Similarity |
NPD1247 |
Approved |
0.708 |
Intermediate Similarity |
NPD4196 |
Clinical (unspecified phase) |
0.7071 |
Intermediate Similarity |
NPD3600 |
Clinical (unspecified phase) |
0.7063 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.705 |
Intermediate Similarity |
NPD1201 |
Approved |
0.7047 |
Intermediate Similarity |
NPD1471 |
Phase 3 |
0.7047 |
Intermediate Similarity |
NPD2343 |
Clinical (unspecified phase) |
0.7039 |
Intermediate Similarity |
NPD7440 |
Discontinued |
0.7029 |
Intermediate Similarity |
NPD4626 |
Approved |
0.7027 |
Intermediate Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.7027 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7023 |
Intermediate Similarity |
NPD2684 |
Approved |
0.7006 |
Intermediate Similarity |
NPD7039 |
Approved |
0.7006 |
Intermediate Similarity |
NPD7038 |
Approved |
0.7006 |
Intermediate Similarity |
NPD7110 |
Phase 1 |
0.7006 |
Intermediate Similarity |
NPD7109 |
Clinical (unspecified phase) |
0.7 |
Intermediate Similarity |
NPD3134 |
Approved |
0.6993 |
Remote Similarity |
NPD3018 |
Phase 2 |
0.6987 |
Remote Similarity |
NPD2649 |
Approved |
0.6987 |
Remote Similarity |
NPD2651 |
Approved |
0.6986 |
Remote Similarity |
NPD4307 |
Phase 2 |
0.6986 |
Remote Similarity |
NPD2979 |
Phase 3 |
0.6981 |
Remote Similarity |
NPD5353 |
Approved |
0.6981 |
Remote Similarity |
NPD2296 |
Approved |
0.6981 |
Remote Similarity |
NPD5402 |
Approved |
0.698 |
Remote Similarity |
NPD2438 |
Suspended |
0.6975 |
Remote Similarity |
NPD7199 |
Phase 2 |
0.6972 |
Remote Similarity |
NPD3266 |
Approved |
0.6972 |
Remote Similarity |
NPD3267 |
Approved |
0.697 |
Remote Similarity |
NPD2163 |
Approved |
0.6968 |
Remote Similarity |
NPD5403 |
Approved |
0.6962 |
Remote Similarity |
NPD37 |
Approved |
0.6962 |
Remote Similarity |
NPD7577 |
Discontinued |
0.6954 |
Remote Similarity |
NPD3060 |
Approved |
0.6948 |
Remote Similarity |
NPD5401 |
Approved |
0.6948 |
Remote Similarity |
NPD3146 |
Approved |
0.6948 |
Remote Similarity |
NPD3688 |
Clinical (unspecified phase) |
0.6948 |
Remote Similarity |
NPD4662 |
Approved |
0.6948 |
Remote Similarity |
NPD7422 |
Clinical (unspecified phase) |
0.6948
|
Remote Similarity |
NPD4661 |
Approved |